Total pancreatectomy for pancreatic cancer: Indications and operative technique

HPB

Volumn 11, Issue 6, 2009, Pages 469-475

  Kulu, Yakup ^a   Schmied, Bruno M ^a   Warner, Jens ^a   Muselli, Pietro ^a   Büchler, Markus W ^a   Schmidt, Jan S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Morbidity; Mortality; Operative technique; Pancreatic cancer; Total pancreatectomy

Indexed keywords

ANASTOMOSIS; CANCER SURVIVAL; FAMILIAL CANCER; HEPATOJEJUNOSTOMY; HIGH RISK PATIENT; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LYMPHADENECTOMY; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS RESECTION; PATIENT SAFETY; QUALITY OF LIFE; REVIEW; SUPERIOR MESENTERIC ARTERY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION;

EID: 70349528169     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00085.x     Document Type: Review

References (55)

1. Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. (1998) Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 228:71-78.
2. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR et al. (2000) Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 232:786-795.
3. Neoptolemos JP, Russell RC, Bramhall S, Theis B. (1997) Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 84:1370-1376.
4. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I. et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137.
5. Weitz J, Koch M, Friess H, Buchler MW. (2004) Impact of volume and specialization for cancer surgery. Dig Surg 21:253-261.
6. van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM et al. (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242:781-788; discussion 788-790.
7. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. (2005) Longterm survival is superior after resection for cancer in high-volume centres. Ann Surg 242:540-544; discussion 544-547.
8. Rockey EW. (1943) Total pancreatectomy for carcinoma: case report. Ann Surg 118:603-611.
9. Ross DE. (1954) Cancer of the pancreas; a plea for total pancreatectomy. Am J Surg 87:20-33.
10. Dresler CM, Fortner JG, McDermott K, Bajorunas DR. (1991) Metabolic consequences of (regional) total pancreatectomy. Ann Surg 214:131-140.
11. McAfee MK, van Heerden JA, Adson MA. (1989) Is proximal pancreatoduodenectomy with pyloric preservation superior to total pancreatectomy? Surgery 105:347-351.
12. Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire WP, Jr. (1986) Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 151:141-149.
13. Nathan H, Wolfgang CL, Edil BH, Choti MA, Herman JM, Schulick RD et al. (2009) Perioperative mortality and longterm survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol 99:87-92.
14. Muller MW, Friess H, Kleeff J, Dahmen R, Wagner M, Hinz U et al. (2007) Is there still a role for total pancreatectomy? Ann Surg 246:966-974; discussion 974-975.
15. Reddy SK, Tyler DS, Pappas TN, Clary BM. (2007) Extended resection for pancreatic adenocarcinoma. Oncologist 12:654-663.
16. Liu SL, Friess H, Kleeff J, Ji ZL, Buchler MW. (2002) Surgical approaches for resection of pancreatic cancer: an overview. Hepatobiliary Pancreat Dis Int 1:118-125.
17. Wagner M, Z'Graggen K, Vagianos CE, Redaelli CA, Holzinger F, Sadowski C et al. (2001) Pylorus-preserving total pancreatectomy. Early and late results. Dig Surg 18:188-195.
18. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'Graggen K. (2003) Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138:1310-1314; discussion 1315.
19. Heidt DG, Burant C, Simeone DM. (2007) Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 11:209-216.
20. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511-518.
21. Hartel M, Wente MN, Di Sebastiano P, Friess H, Buchler MW. (2004) The role of extended resection in pancreatic adenocarcinoma: is there good evidence-based justification? Pancreatology 4:561-566.
22. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586-594.
23. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H et al. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035-1046.
24. Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q et al. (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142:572-578; discussion 578-580.
25. Z'Graggen K, Uhl W, Friess H, Buchler MW. (2002) How to do a safe pancreatic anastomosis. J Hepatobiliary Pancreat Surg 9:733-737.
26. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199-1210; discussion 1210-1211.
27. Welsch T, Frommhold K, Hinz U, Weigand MA, Kleeff J, Friess H et al. (2008) Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery 143:20-28.
28. Munoz-Bongrand N, Sauvanet A, Denys A, Sibert A, Vilgrain V, Belghiti J. (2004) Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 199: 198-203.
29. Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H et al. (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193:171-183.
30. Buchler MW, Kleeff J, Friess H. (2007) Surgical treatment of pancreatic cancer. J Am Coll Surg 205 (Suppl):81-86.
31. van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. (1997) Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 185:18-24.
32. Muscari F, Suc B, Kirzin S, Hay J M, Fourtanier G, Fingerhut A et al. (2006) Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 139:591-598.
33. Bartoli FG, Arnone GB, Ravera G, Bachi V. (1991) Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 11:1831-1848.
34. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. (2004) Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 8:951-959.
35. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD et al. (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141-145.
36. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Maire F, Hammel P et al. (2008) Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 103:111-119.
37. Kekis PB, Friess H, Kleeff J, Buchler MW. (2001) Timing and extent of surgical intervention in patients from hereditary pancreatic cancer kindreds. Pancreatology 1:525-530.
38. Brentnall TA. (2005) Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol 6:437-445.
39. Furukawa T, Takahashi T, Kobari M, Matsuno S. (1992) The mucus-hypersecreting tumour of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer 70: 1505-1513.
40. Bassi C, Sarr MG, Lillemoe KD, Reber HA. (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12:645-650.
41. Wente MN, Schmied BM, Schmidt J, Buchler MW. (2009) [Differentiated therapy for intraductal papillary mucinous neoplasms.] Chirurg 80:7-13.
42. Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M et al. (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123: 1500-1507.
43. Paye F, Sauvanet A, Terris B, Ponsot P, Vilgrain V, Hammel P et al. (2000) Intraductal papillary mucinous tumours of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 127:536-544.
44. Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nishio K, Nagao M et al. (1998) Pattern of recurrence after resection for intraductal papillary mucinous tumours of the pancreas. World J Surg 22:874-878.
45. Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G et al. (2000) Intraductal papillary mucinous tumours of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 24: 1372-1377.
46. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17-32.
47. Al-Haddad M, Martin JK, Nguyen J, Pungpapong S, Raimondo M, Woodward T et al. (2007) Vascular resection and reconstruction for pancreatic malignancy: a single-centre survival study. J Gastrointest Surg 11:1168-1174.
48. Siriwardana HPP, Siriwardena AK. (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93:662-673.
49. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK et al. (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935-949; discussion 949-950.
50. Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK et al. (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and longterm survival in 136 patients. Ann Surg 247:300-309.
51. Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M et al. (2002) Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 168:707-712.
52. Weitz J, Kienle P, Schmidt J, Friess H, Buchler MW. (2007) Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 204: 712-716.
53. Hartel M, Wente MN, Hinz U, Kleeff J, Wagner M, Muller MW et al. (2005) Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 140:1094-1099.
54. Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG et al. (2005) Quality of life after total pancreatectomy: is it really that bad on longterm follow-up? J Gastrointest Surg 9:1059-1066; discussion 1066-1067.
55. Tattersall RB. (1997) Brittle diabetes revisited: the Third Arnold Bloom Memorial Lecture. Diabet Med 14:99-110.